Cargando…

Protocol for intranasal chemoprevention delivery in a urethane mouse lung cancer model

Mouse iloprost lung cancer chemoprevention studies typically use oral delivery. Here, we present a protocol for intranasal iloprost delivery within a urethane lung adenocarcinoma mouse model. We detail steps for intraperitoneal urethane injection in mice, followed by nine-week monitoring, intranasal...

Descripción completa

Detalles Bibliográficos
Autores principales: Dwyer-Nield, Lori, Keith, Robert L., Tennis, Meredith A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9535317/
https://www.ncbi.nlm.nih.gov/pubmed/36201319
http://dx.doi.org/10.1016/j.xpro.2022.101750
_version_ 1784802745013764096
author Dwyer-Nield, Lori
Keith, Robert L.
Tennis, Meredith A.
author_facet Dwyer-Nield, Lori
Keith, Robert L.
Tennis, Meredith A.
author_sort Dwyer-Nield, Lori
collection PubMed
description Mouse iloprost lung cancer chemoprevention studies typically use oral delivery. Here, we present a protocol for intranasal iloprost delivery within a urethane lung adenocarcinoma mouse model. We detail steps for intraperitoneal urethane injection in mice, followed by nine-week monitoring, intranasal iloprost treatment, and lungs harvesting for analysis. This iloprost delivery approach parallels an ongoing phase II clinical trial of inhaled iloprost for lung cancer chemoprevention. This protocol diversifies options for chemoprevention studies and offers a relevant and translatable model. For complete details on the use and execution of this protocol, please refer to Sompel et al. (2022).
format Online
Article
Text
id pubmed-9535317
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Elsevier
record_format MEDLINE/PubMed
spelling pubmed-95353172022-10-07 Protocol for intranasal chemoprevention delivery in a urethane mouse lung cancer model Dwyer-Nield, Lori Keith, Robert L. Tennis, Meredith A. STAR Protoc Protocol Mouse iloprost lung cancer chemoprevention studies typically use oral delivery. Here, we present a protocol for intranasal iloprost delivery within a urethane lung adenocarcinoma mouse model. We detail steps for intraperitoneal urethane injection in mice, followed by nine-week monitoring, intranasal iloprost treatment, and lungs harvesting for analysis. This iloprost delivery approach parallels an ongoing phase II clinical trial of inhaled iloprost for lung cancer chemoprevention. This protocol diversifies options for chemoprevention studies and offers a relevant and translatable model. For complete details on the use and execution of this protocol, please refer to Sompel et al. (2022). Elsevier 2022-10-04 /pmc/articles/PMC9535317/ /pubmed/36201319 http://dx.doi.org/10.1016/j.xpro.2022.101750 Text en © 2022 The Authors https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
spellingShingle Protocol
Dwyer-Nield, Lori
Keith, Robert L.
Tennis, Meredith A.
Protocol for intranasal chemoprevention delivery in a urethane mouse lung cancer model
title Protocol for intranasal chemoprevention delivery in a urethane mouse lung cancer model
title_full Protocol for intranasal chemoprevention delivery in a urethane mouse lung cancer model
title_fullStr Protocol for intranasal chemoprevention delivery in a urethane mouse lung cancer model
title_full_unstemmed Protocol for intranasal chemoprevention delivery in a urethane mouse lung cancer model
title_short Protocol for intranasal chemoprevention delivery in a urethane mouse lung cancer model
title_sort protocol for intranasal chemoprevention delivery in a urethane mouse lung cancer model
topic Protocol
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9535317/
https://www.ncbi.nlm.nih.gov/pubmed/36201319
http://dx.doi.org/10.1016/j.xpro.2022.101750
work_keys_str_mv AT dwyernieldlori protocolforintranasalchemopreventiondeliveryinaurethanemouselungcancermodel
AT keithrobertl protocolforintranasalchemopreventiondeliveryinaurethanemouselungcancermodel
AT tennismereditha protocolforintranasalchemopreventiondeliveryinaurethanemouselungcancermodel